痰热清注射液治疗儿童急性呼吸道感染的临床观察

发布时间：2018-03-03 21:21

本文选题：痰热清注射液　切入点：儿童　出处：《中药药理与临床》2017年02期 　论文类型：期刊论文

【摘要】：目的:观察痰热清注射液治疗儿童急性呼吸道感染的临床疗效。方法:回顾分析2015年11月至2016年11月期间在我院治疗的96例儿童急性呼吸道感染患儿临床资料,将其随机分为对照组和治疗组,每组48例患儿,对照组采用止咳、祛痰、解痉等对症治疗,治疗组在对照组治疗基础上给予痰热清注射液治疗,治疗1个疗程(1个疗程7d),第8天评价两组患儿临床治疗效果。结果:治疗7天后,治疗组患儿临床治疗总有效率95.83%,对照组患儿临床治疗总有效率为77.08%,两组对比差异有统计学意义;治疗后治疗组患儿临床症状(发热、咳嗽、咳痰、气喘)改善时间明显短于对照组;治疗后两组患儿临床症状评分明显降低,与治疗前对比差异有统计学意义,治疗组临床症状评分明显低于对照组;治疗后两组患儿T淋巴细胞、CD4+水平明显升高,治疗组T淋巴细胞、CD4+水平明显高于对照组;治疗后两组患儿白细胞(WBC)、C-反应蛋白(CRP)明显下降,治疗组WBC、CRP明显低于对照组;在治疗和观察期间,对照组出现2例胃肠不良反应,治疗组无不良良反应。结论:痰热清注射液治疗儿童急性呼吸道感染效果显著,可快速改善患儿临床症状,提高患儿免疫功能。
[Abstract]:Objective: to observe the clinical effect of Tanreqing injection on acute respiratory tract infection in children. Methods: the clinical data of 96 children with acute respiratory tract infection treated in our hospital from November 2015 to November 2016 were retrospectively analyzed. They were randomly divided into control group and treatment group. Each group had 48 children. The control group was treated with antitussive, expectorant and spasmodic treatment, and the treatment group was treated with Tanreqing injection on the basis of control group. One course of treatment (1 course of 7 days, 8 days) was used to evaluate the clinical effect of the two groups. Results: after 7 days of treatment, The total effective rate of clinical treatment in the treatment group was 95.83 and that in the control group was 77.08, the difference between the two groups was statistically significant, and the clinical symptoms (fever, cough, expectoration, sputum) in the treatment group after treatment were statistically significant. The improvement time of asthma was shorter than that of the control group, the clinical symptom score of the two groups was significantly lower than that of the control group after treatment, and the difference between the two groups was statistically significant, and the clinical symptom score of the treatment group was obviously lower than that of the control group. After treatment, the level of T lymphocyte count CD4 in the treatment group was significantly higher than that in the control group, and the level of WBCU C-reactive protein (CRP) in the treatment group was significantly lower than that in the control group, and that in the treatment group was significantly lower than that in the control group. During the course of treatment and observation, there were 2 cases of gastrointestinal adverse reactions in the control group, but no adverse reactions in the treatment group. Conclusion: Tanreqing injection is effective in treating children with acute respiratory tract infection, and can improve the clinical symptoms of children quickly. To improve the immune function of children.
【作者单位】：唐山市工人医院儿科;
【分类号】：R272

【相似文献】